Colorado State University
Dr. Alan Rudolph
Dr. Alan S. Rudolph is the Vice President for Research at Colorado State University. He is a former member of the Senior Executive Service, having served as the Director for Joint Science and Technology under the Assistant Secretary of Defense and Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA).
Dr. Rudolph has had an active career in translating interdisciplinary life sciences into useful applications for biotechnology development. During his tenure at DTRA, he oversaw discovery and clinical validation of new countermeasures for biological and chemical threats.
After a decade at the Naval Research Laboratory where he led the Navy’s blood substitute program, Dr. Rudolph joined the Defense Advanced Research Projects Agency (DARPA) to lead efforts to extract and exploit life science principles and practices for Defense applications. At DARPA, he led the first brain-machine interface program, as well as efforts to create bio-inspired robotics, new sensors, diagnostics, and devices. He received a meritorious civil service citation from the Office of the Secretary of Defense for his contributions to defining and implementing a new generation of life sciences and national security investments.
As Chief Executive Officer of Adlyfe, Inc., a diagnostic platform company, and Board Chairman of Cellphire, Inc., Dr. Rudolph focused on development of novel hemostatic biologics for bleeding injuries. His current interests include the use of immersive virtual and augmented reality to deliver novel health outcomes.
Dr. Rudolph has a doctorate degree in zoology from the University of California at Davis and an MBA from George Washington University.